Pepgen Inc (PEPG)

$1.54 -0.05 (-3.14%)
Market Cap 109.89M
Revenue (ttm) 0.00
Net Income (ttm) -89.66M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 581,600
Avg Vol 1,513,036
Day's Range N/A - N/A
Shares Out 69.12M
Stochastic %K 4%
Beta 2.34
Analysts Strong Sell
Price Target $10.29

Company Profile

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study....

Industry: Biotechnology
Sector: Healthcare
Phone: 781 797 0979
Address:
321 Harrison Avenue, 8th Floor, Boston, United States
mpired
mpired Apr. 24 at 9:19 PM
$PEPG saw the dip and bought it. now dont make me regret it
0 · Reply
Cbruffyh
Cbruffyh Apr. 24 at 10:34 AM
$PEPG can we get a the partial lift removed!
0 · Reply
Bebbz88
Bebbz88 Apr. 21 at 1:15 PM
$PEPG todays going to be good here
0 · Reply
Bebbz88
Bebbz88 Apr. 20 at 5:29 PM
$PEPG 7000 shares @ 1.71 lets see what this thing can do.
1 · Reply
Silverstripe
Silverstripe Apr. 17 at 2:09 PM
$PEPG somehow it feels like there is something cooking and it will bounce any moment soon
0 · Reply
abasol64
abasol64 Apr. 16 at 7:03 PM
$PEPG got some...rebound?
0 · Reply
Silverstripe
Silverstripe Apr. 15 at 6:35 PM
$PEPG Some tongs of liquidity… let’s see. Let see
0 · Reply
Johann00
Johann00 Apr. 14 at 1:04 AM
$PEPG Nice little overnight pump! Let's keep it going, my $2.00 calls would really appreciate it!!
0 · Reply
pal123
pal123 Apr. 9 at 2:05 PM
$INTC check $PEPG
0 · Reply
LordWorld
LordWorld Apr. 7 at 12:15 PM
$PEPG 🦬🦬🦬🦬🦬🦬🚀🚀🚀🚀🚀Buy
0 · Reply
Latest News on PEPG
PepGen Transcript: Study update

Mar 31, 2026, 4:30 PM EDT - 25 days ago

PepGen Transcript: Study update

PepGen Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Mar 31, 2026, 10:33 AM EDT - 25 days ago

PepGen Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data

Mar 30, 2026, 4:05 PM EDT - 26 days ago

PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data

PepGen Transcript: Leerink Global Healthcare Conference 2026

Mar 10, 2026, 3:00 PM EDT - 6 weeks ago

PepGen Transcript: Leerink Global Healthcare Conference 2026

US FDA puts partial clinical hold on PepGen's muscle disease drug trial

Mar 4, 2026, 4:56 PM EST - 7 weeks ago

US FDA puts partial clinical hold on PepGen's muscle disease drug trial

PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights

Mar 4, 2026, 4:05 PM EST - 7 weeks ago

PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights

PepGen Announces Regulatory Updates on FREEDOM2

Mar 4, 2026, 4:03 PM EST - 7 weeks ago

PepGen Announces Regulatory Updates on FREEDOM2

PepGen to Participate in the Leerink Global Healthcare Conference

Mar 3, 2026, 7:00 AM EST - 7 weeks ago

PepGen to Participate in the Leerink Global Healthcare Conference

PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer

Dec 9, 2025, 7:00 AM EST - 4 months ago

PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer

PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer

Dec 8, 2025, 7:00 AM EST - 4 months ago

PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer

PepGen Transcript: Stifel 2025 Healthcare Conference

Nov 13, 2025, 4:00 PM EST - 5 months ago

PepGen Transcript: Stifel 2025 Healthcare Conference

PepGen Announces Issuance of U.S. Patent for Proprietary PGN-EDODM1 Molecule

Nov 12, 2025, 7:05 AM EST - 5 months ago

PepGen Announces Issuance of U.S. Patent for Proprietary PGN-EDODM1 Molecule

PepGen Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

Nov 12, 2025, 7:00 AM EST - 5 months ago

PepGen Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

PepGen Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Nov 10, 2025, 11:30 AM EST - 5 months ago

PepGen Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference

PepGen to Participate in Upcoming Investor Conferences

Nov 3, 2025, 7:00 AM EST - 6 months ago

PepGen to Participate in Upcoming Investor Conferences

PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society

Oct 2, 2025, 7:00 AM EDT - 7 months ago

PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society

PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

Sep 26, 2025, 4:01 PM EDT - 7 months ago

PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

PepGen Reports Highest Splicing Correction In Dystrophy Patients, Stock Doubles

Sep 25, 2025, 9:46 AM EDT - 7 months ago

PepGen Reports Highest Splicing Correction In Dystrophy Patients, Stock Doubles

PepGen Announces Pricing of $100 Million Public Offering

Sep 24, 2025, 10:51 PM EDT - 7 months ago

PepGen Announces Pricing of $100 Million Public Offering

PepGen Announces Proposed Public Offering

Sep 24, 2025, 4:21 PM EDT - 7 months ago

PepGen Announces Proposed Public Offering

PepGen Announces Highest Mean Splicing Correction Reported in DM1 Patients

Sep 24, 2025, 4:16 PM EDT - 7 months ago

PepGen Announces Highest Mean Splicing Correction Reported in DM1 Patients

PepGen Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Aug 7, 2025, 8:00 AM EDT - 9 months ago

PepGen Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

Jul 30, 2025, 5:41 PM EDT - 9 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

Jul 29, 2025, 10:33 AM EDT - 9 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

Jul 23, 2025, 11:22 AM EDT - 9 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of PepGen

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 8, 2025 in PepGen Inc. Lawsuit - PEPG

Jun 23, 2025, 9:00 AM EDT - 10 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 8, 2025 in PepGen Inc. Lawsuit - PEPG

Shareholders who lost money on PepGen Inc. (NASDAQ: PEPG) Should Contact Wolf Haldenstein

Jun 16, 2025, 10:39 AM EDT - 11 months ago

Shareholders who lost money on PepGen Inc. (NASDAQ: PEPG) Should Contact Wolf Haldenstein

PEPGEN INC. (NASDAQ: PEPG) INVESTOR ALERT Investors With Large Losses in PepGen Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Jun 10, 2025, 10:44 AM EDT - 11 months ago

PEPGEN INC. (NASDAQ: PEPG) INVESTOR ALERT Investors With Large Losses in PepGen Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

PepGen Abandons Duchenne Program, Shifts Spotlight To Another Rare Disease Candidate

May 29, 2025, 9:19 AM EDT - 11 months ago

PepGen Abandons Duchenne Program, Shifts Spotlight To Another Rare Disease Candidate

PepGen to discontinue development of experimental Duchenne therapy; shares drop

May 28, 2025, 6:21 PM EDT - 11 months ago

PepGen to discontinue development of experimental Duchenne therapy; shares drop

PepGen to Focus on Development of Promising DM1 Program Following 10 mg/kg PGN-EDO51 Update

May 28, 2025, 4:05 PM EDT - 11 months ago

PepGen to Focus on Development of Promising DM1 Program Following 10 mg/kg PGN-EDO51 Update

PepGen Appoints Kasra Kasraian, PhD, as Chief Technology Officer

May 20, 2025, 7:00 AM EDT - 1 year ago

PepGen Appoints Kasra Kasraian, PhD, as Chief Technology Officer

PepGen Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

May 8, 2025, 8:00 AM EDT - 1 year ago

PepGen Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

PepGen Transcript: 24th Annual Needham Virtual Healthcare Conference

Apr 9, 2025, 1:30 PM EDT - 1 year ago

PepGen Transcript: 24th Annual Needham Virtual Healthcare Conference

PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 2, 2025, 4:05 PM EDT - 1 year ago

PepGen to Present at the 24th Annual Needham Virtual Healthcare Conference

PepGen Transcript: Virtual CNS Forum

Mar 19, 2025, 8:00 AM EDT - 1 year ago

PepGen Transcript: Virtual CNS Forum

PepGen Transcript: Leerink’s Global Healthcare Conference 2025

Mar 11, 2025, 3:00 PM EDT - 1 year ago

PepGen Transcript: Leerink’s Global Healthcare Conference 2025

PepGen Transcript: Study Update

Feb 24, 2025, 8:00 AM EST - 1 year ago

PepGen Transcript: Study Update

PepGen Transcript: Corporate Presentation

Jul 30, 2024, 7:00 AM EDT - 1 year ago

PepGen Transcript: Corporate Presentation

PepGen Earnings Call Transcript: Q4 2023

Mar 6, 2024, 4:30 PM EST - 2 years ago

PepGen Earnings Call Transcript: Q4 2023

mpired
mpired Apr. 24 at 9:19 PM
$PEPG saw the dip and bought it. now dont make me regret it
0 · Reply
Cbruffyh
Cbruffyh Apr. 24 at 10:34 AM
$PEPG can we get a the partial lift removed!
0 · Reply
Bebbz88
Bebbz88 Apr. 21 at 1:15 PM
$PEPG todays going to be good here
0 · Reply
Bebbz88
Bebbz88 Apr. 20 at 5:29 PM
$PEPG 7000 shares @ 1.71 lets see what this thing can do.
1 · Reply
Silverstripe
Silverstripe Apr. 17 at 2:09 PM
$PEPG somehow it feels like there is something cooking and it will bounce any moment soon
0 · Reply
abasol64
abasol64 Apr. 16 at 7:03 PM
$PEPG got some...rebound?
0 · Reply
Silverstripe
Silverstripe Apr. 15 at 6:35 PM
$PEPG Some tongs of liquidity… let’s see. Let see
0 · Reply
Johann00
Johann00 Apr. 14 at 1:04 AM
$PEPG Nice little overnight pump! Let's keep it going, my $2.00 calls would really appreciate it!!
0 · Reply
pal123
pal123 Apr. 9 at 2:05 PM
$INTC check $PEPG
0 · Reply
LordWorld
LordWorld Apr. 7 at 12:15 PM
$PEPG 🦬🦬🦬🦬🦬🦬🚀🚀🚀🚀🚀Buy
0 · Reply
topstockalerts
topstockalerts Apr. 6 at 9:28 PM
$PEPG $2+ ahead
0 · Reply
pal123
pal123 Apr. 6 at 9:07 PM
$FCUV $PFSA $AIXI Check $PEPG stock, it is at discount now. great potential. 🎉
0 · Reply
OG_Monkey_Banana_Genius
OG_Monkey_Banana_Genius Apr. 6 at 8:05 PM
$PEPG remember you looked at this one too? @sogenerous - this is typical precommercial outcome. ERAS is a huge outlier.
1 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Apr. 6 at 6:23 PM
$PEPG I told u it wasn't done if u sold before this pop.. Learn those charts... Nice money from our entry... And may not be done yet... Trump is talking🤔
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Apr. 6 at 2:52 PM
$PEPG Newbies thought this was done and sold their little shares .... Keep it going.. $1.79 Light resistance.. Let it break.. Good day so far ⚡⚡⚡⚡
1 · Reply
assetmogul2
assetmogul2 Apr. 6 at 1:18 PM
$PEPG if the price targets still around $5, why is this at $1.72? I saw the drop and bought 10000 shares as a flyer.
1 · Reply
PLATINUM_TRADES
PLATINUM_TRADES Apr. 6 at 3:46 AM
$PEPG Ready for the real bounce? They always bounce over $2.00 soon 🚨 🚨
0 · Reply
TravisBking87
TravisBking87 Apr. 3 at 4:06 PM
$PEPG Thank you Jack I made almost 9 K here because of you!
1 · Reply
asedu1968
asedu1968 Apr. 2 at 5:29 PM
$PEPG pun tang na man no !!!! up down up down
0 · Reply
asedu1968
asedu1968 Apr. 2 at 4:44 PM
$PEPG let's effing go
0 · Reply
assetmogul2
assetmogul2 Apr. 2 at 3:42 PM
$PEPG holy up and down action. What a ride
0 · Reply
LordWorld
LordWorld Apr. 2 at 1:35 PM
$PEPG
0 · Reply